Brief: Helix Biopharma Says L-Dos47 Phase I Lung Cancer Trial Data To Be Released At Asco 2020
14/05/2020 12:38
May 14 (Reuters) - Helix Biopharma Corp HBP.TO :
* HELIX BIOPHARMA CORP. L-DOS47 PHASE I LUNG CANCER TRIAL
DATA TO
BE RELEASED AT ASCO 2020
Source text for Eikon: ID:nGNX1NHZdf
Further company coverage: HBP.TO
((Reuters Messaging: Reuters.Briefs@thomsonreuters.com))
Recent news on Helix Biopharma
See all newsBrief: Helix Biopharma Reports Q3 Loss Per Share C$0.02
Brief: Helix Biopharma Intends To File Interim Consolidated Financial Statements By July 30
Brief: Helix Biopharma To Divest Remaining Ownership Of Polish Subsidiary
Brief: Helix Biopharma Says Expects To File Interim Disclosure Documents By July 30, 2020
Brief: Helix Biopharma Says L-Dos47 Phase I Lung Cancer Trial Data To Be Released At Asco 2020